Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia 20007, USA.
Cancer. 2010 Oct 15;116(20):4703-10. doi: 10.1002/cncr.25229.
Evidence suggests that colorectal cancer (CRC) screening reduces disease-specific mortality, whereas the utility of prostate cancer screening remains uncertain. However, adherence rates for prostate cancer screening and CRC screening are very similar, with population-based studies showing that approximately 50% of eligible US men are adherent to both tests. Among men scheduled to participate in a free prostate cancer screening program, the authors assessed the rates and correlates of CRC screening to determine the utility of this setting for addressing CRC screening nonadherence.
Participants (N = 331) were 50 to 70 years old with no history of prostate cancer or CRC. Men registered for free prostate cancer screening and completed a telephone interview 1 to 2 weeks before undergoing prostate cancer screening.
One half of the participants who underwent free prostate cancer screening were eligible for but nonadherent to CRC screening. Importantly, 76% of the men who were nonadherent to CRC screening had a regular physician and/or health insurance, suggesting that CRC screening adherence was feasible in this group. Furthermore, multivariate analyses indicated that the only significant correlates of CRC screening adherence were having a regular physician, health insurance, and a history of prostate cancer screening.
Free prostate cancer screening programs may provide a teachable moment to increase CRC screening among men who may not have the usual systemic barriers to CRC screening, at a time when they may be very receptive to cancer screening messages. In the United States, a large number of men participate in annual free prostate cancer screening programs and represent an easily accessible and untapped group that can benefit from interventions to increase CRC screening rates.
有证据表明,结直肠癌(CRC)筛查可降低疾病特异性死亡率,而前列腺癌筛查的效用仍不确定。然而,前列腺癌筛查和 CRC 筛查的依从率非常相似,基于人群的研究表明,大约有 50%符合条件的美国男性同时接受这两种检查。在计划参加免费前列腺癌筛查计划的男性中,作者评估了 CRC 筛查的比率和相关性,以确定这种环境对解决 CRC 筛查不依从的效用。
参与者(N=331)年龄在 50 至 70 岁之间,无前列腺癌或 CRC 病史。男性注册免费前列腺癌筛查,并在进行前列腺癌筛查前 1 至 2 周完成电话访谈。
一半接受免费前列腺癌筛查的参与者符合但未接受 CRC 筛查。重要的是,76%未接受 CRC 筛查的男性有常规医生和/或健康保险,表明该组可以接受 CRC 筛查。此外,多变量分析表明,CRC 筛查依从性的唯一显著相关因素是有常规医生、健康保险和前列腺癌筛查史。
免费前列腺癌筛查计划可能为那些可能没有 CRC 筛查常见系统障碍的男性提供一个可教育的时刻,以增加 CRC 筛查率,此时他们可能非常愿意接受癌症筛查信息。在美国,大量男性参加年度免费前列腺癌筛查计划,代表着一个容易接触和未开发的群体,可以从提高 CRC 筛查率的干预措施中受益。